MLS is making its return to The Magic City in 2025 with Birmingham Legion FC announcing on Wednesday that it will begin its ...

Petros Pharmaceuticals, Inc. ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, ...

A record number of travelers are expected to hit the roads and skies this holiday season, and where they're going may surprise you. Squaremouth.com, the nation's leading travel insurance marketplace, ...

North American Van Lines is pleased to release the 2024 Annual Migration Map. This yearly report uses state-to-state movement data to highlight trends in population movements within the U.S. The ...

Curi Bio, the industry leader in delivering human functional data to the drug discovery community, and Novoheart, maker of the industry's most sophisticated and comprehensive human cardiac tissue ...

Radius Care, a leading AI-powered healthcare platform, has announced its readiness to collaborate with the Department of Government Efficiency (DOGE) to deliver transformative savings and improve ...

Stryten Energy LLC, a U.S.-based energy storage solutions provider, today announced the signing of agreements by one of its affiliates, Stryten Critical E-Storage LLC, with a subsidiary of Largo Inc.

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that two of the Company's independent ...

CURITIBA, Brazil, Dec. 19, 2024 /PRNewswire/ -- In Brazil, global companies offering instalments as a payment solution ...

As 2024 draws to a close, Drofa Comms concludes the year with record-breaking achievements and sets ambitious plans for the future. In 2024, the agency achieved an impressive growth rate of 69.5% and ...

The practice of "one country, two systems" with Macao characteristics has achieved success widely recognized by the world, showcasing great vitality and unique charm, said Chinese President Xi Jinping ...

Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for the ...